Recent Advances in the Treatment of Huntington’s Disease: Targeting DNA and RNA Kathleen M. Shannon LEADING ARTICLE 13 January 2020 Pages: 219 - 228
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety Simona LattanziFrancesco BrigoMauro Silvestrini Systematic Review 10 February 2020 Pages: 229 - 241
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates Monika MarcinkowskaJoanna ŚniecikowskaMarcin Kołaczkowski Review Article Open access 12 February 2020 Pages: 243 - 268
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis Finn SellebjergMorten BlinkenbergPer Soelberg Sorensen Review Article 28 January 2020 Pages: 269 - 280
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease Lucia CaffinoFrancesca MottarliniFabio Fumagalli Review Article 12 February 2020 Pages: 281 - 297
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program Teodora DohertyEwa WajsMichael A. Weber Original Research Article Open access 29 January 2020 Pages: 299 - 310
Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug Muriel RichardPriska KaufmannJasper Dingemanse Original Research Article 28 January 2020 Pages: 311 - 323
